Anne-Sofie Furberg Selected Research

Obesity

1/2021	Exposure to perfluoroalkyl substances (PFAS) and dyslipidemia, hypertension and obesity in adolescents. The Fit Futures study.
8/2004	Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
5/2003	Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne-Sofie Furberg Research Topics

Disease

12	Breast Neoplasms (Breast Cancer) 01/2016 - 08/2004
6	Overweight 11/2023 - 05/2003
4	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2023 - 03/2017
3	Insulin Resistance 01/2022 - 06/2008
3	Hypertension (High Blood Pressure) 01/2021 - 05/2003
3	Obesity 01/2021 - 05/2003
3	Birth Weight (Birth Weights) 12/2017 - 03/2009
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2008 - 08/2004
2	Inflammation (Inflammations) 01/2020 - 01/2017
2	Pain (Aches) 01/2020 - 01/2017
1	Vitamin D Deficiency 11/2023
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Osteoporosis 01/2021
1	Isolated Systolic Hypertension 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Hypersensitivity (Allergy) 01/2019
1	Asthma (Bronchial Asthma) 01/2019
1	Weight Gain 03/2017
1	Chronic Pain 01/2017
1	Noncommunicable Diseases 01/2017
1	Neoplasms (Cancer) 01/2017
1	Infections 11/2012
1	Carcinogenesis 05/2009
1	Body Weight (Weight, Body) 03/2009
1	Glucose Intolerance 08/2004
1	Endometrial Neoplasms (Endometrial Cancer) 05/2003
1	Chronic Disease (Chronic Diseases) 05/2003

Drug/Important Bio-Agent (IBA)

6	HDL CholesterolIBA 06/2015 - 08/2004
5	Estrogens (Estrogen)FDA Link 01/2016 - 01/2005
5	N-(4-ethoxybenzylidene)-4-butylanilineIBA 08/2015 - 06/2007
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2005
3	Hormones (Hormone)IBA 01/2017 - 01/2005
3	Progesterone FDA LinkGeneric 01/2016 - 05/2012
3	Triglycerides (Triacylglycerol)IBA 05/2012 - 08/2004
2	hydroxide ionIBA 11/2023 - 01/2023
2	25-hydroxyvitamin DIBA 11/2023 - 01/2023
2	MineralsIBA 01/2021 - 12/2017
2	perflexane (perfluorohexane)FDA Link 01/2021 - 01/2019
2	CholesterolIBA 05/2012 - 06/2008
2	LipidsIBA 06/2010 - 06/2008
2	Insulin (Novolin)FDA Link 05/2009 - 06/2008
2	Estradiol (Delestrogen)FDA LinkGeneric 03/2009 - 01/2005
2	Glucose (Dextrose)FDA LinkGeneric 06/2008 - 05/2003
1	ORALIT (ORS)IBA 11/2023
1	Vitamin D FDA LinkGeneric 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Thyroid HormonesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	oxidized low density lipoproteinIBA 01/2021
1	perfluorooctanoic acidIBA 01/2021
1	perfluoroheptanesulfonic acidIBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2020
1	perfluorooctaneIBA 01/2019
1	NickelIBA 01/2019
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2019
1	Polysorbates (PSML)FDA Link 03/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	C-Reactive ProteinIBA 01/2017
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2017
1	AndrogensIBA 08/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2014
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 05/2012
1	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 01/2012

Therapy/Procedure

1	Condoms (Condom) 11/2012